Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)
about
Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)
description
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 June 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2011
@uk
name
Phase II clinical trial with g ...... -cell lung cancer (SLCG 01-04)
@en
Phase II clinical trial with g ...... ced non-small-cell lung cancer
@nl
type
label
Phase II clinical trial with g ...... -cell lung cancer (SLCG 01-04)
@en
Phase II clinical trial with g ...... ced non-small-cell lung cancer
@nl
prefLabel
Phase II clinical trial with g ...... -cell lung cancer (SLCG 01-04)
@en
Phase II clinical trial with g ...... ced non-small-cell lung cancer
@nl
P2093
P50
P1476
Phase II clinical trial with g ...... -cell lung cancer (SLCG 01-04)
@en
P2093
Alfredo Carrato
Amalia Velasco
Ana Blasco
Bertomeu Massuti
Eloísa Jantus
Lorenzo Gómez-Aldaraví
Mireia Gil
Rafael Rossell
Ricardo Guijarro
Vega Iranzo
P2888
P304
P356
10.1007/S12094-011-0675-0
P50
P577
2011-06-01T00:00:00Z
P6179
1007291033